SCIENTIFIC BACKGROUND

ABCC6, ACTA2, ACVR1, ADAMTS2, ALDH18A1, ATP6V0A2, ATP6V1A, ATP6V1E1, B3GALT6, B4GALT7, BGN, C1R, C1S, CBS, CHST14, COL1A1, COL1A2, COL3A1, COL4A1, COL5A1, COL5A2, DSE, EFEMP2, ELN, FBLN5, FBN1, FBN2, FKBP14, FOXE3, GORAB, LOX, LTBP4, MFAP5, MYH11, MYLK, PLOD1, PRDM5, PYCR1, SKI, SLC2A10, SLC39A13, SMAD3, SMAD4, TGFB2, TGFB3, TGFBR1, TGFBR2, ZNF469

Category:

Scientific Background

Aortopathy is any disease affecting the aorta, the largest artery of the circulatory system, which is directly connected to the heart and is the starting point of blood transportation to the entire body. Aortopathies are considered a significant burden on healthcare systems internationally as they are responsible for early mortality, there is an increased number of incidences, and often they go undiagnosed until a major health complication.

 

Hereditary aortopathies are even more underdiagnosed. Early identification of genetic mutations in genes known to be associated with hereditary aortopathies, through genetic testing, can provide valuable information to the healthcare provider for better surveillance and timing of prophylactic repair, more accurate prognosis, and offering a more personalized therapy based on the patient’s specific genetic mutation.

 

Who is this test for?

The most recent guidelines for the diagnosis and management of aortic disease, published by the American College of Cardiology and the American Heart Association in November 2022, highlight the importance of genetic testing for people with

  • syndromic features
  • family history of thoracic aortic disease or
  • early symptoms of aortopathy

Genetic testing can identify pathogenic variants in genes known to be associated with aortopathies in patients with increased risk of aneurysm, dissection, or both, and inform the healthcare provider for optimal timing for prophylactic assessment or therapy.

 

References

  • Goyal A, Keramati AR, Czarny MJ, Resar JR, Mani A. The Genetics of Aortopathies in Clinical Cardiology. Clin Med Insights Cardiol. 2017 May 30;11:1179546817709787. doi: 10.1177/1179546817709787. PMID: 28607545; PMCID: PMC5457142.
  • Isselbacher, E. M., Preventza, O., Hamilton Black, J., Augoustides, J. G., Beck, A. W., Bolen, M. A., Braverman, A. C., Bray, B. E., Brown-Zimmerman, M. M., Chen, E. P., Collins, T. J., DeAnda, A., Fanola, C. L., Girardi, L. N., Hicks, C. W., Hui, D. S., Schuyler Jones, W., Kalahasti, V., Kim, K. M., . . . Woo, Y. J. (2022). 2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation, 146(24). https://doi.org/10.1161/cir.0000000000001106

 

How many genes are tested in this panel?

48 genes

 

What diseases are associated with the genes tested in this panel?

  • Marfan syndrome
  • Ehlers-Danlos syndrome
  • Loeys-Dietz syndrome
  • Familial Thoracic Aortic Aneurysm and Dissections
  • Bicuspid Aortic Valve Disease

GENES

ABCC6, ACTA2, ACVR1, ADAMTS2, ALDH18A1, ATP6V0A2, ATP6V1A, ATP6V1E1, B3GALT6, B4GALT7, BGN, C1R, C1S, CBS, CHST14, COL1A1, COL1A2, COL3A1, COL4A1, COL5A1, COL5A2, DSE, EFEMP2, ELN, FBLN5, FBN1, FBN2, FKBP14, FOXE3, GORAB, LOX, LTBP4, MFAP5, MYH11, MYLK, PLOD1, PRDM5, PYCR1, SKI, SLC2A10, SLC39A13, SMAD3, SMAD4, TGFB2, TGFB3, TGFBR1, TGFBR2, ZNF469
How to order

LATEST ARTICLES

Carrier screening is a genetic test designed to identify whether an individual carries a gene with changes (mutations) associated with inherited diso...

Read more

Trisomy 13, also known as Patau syndrome, is a genetic condition in which cells in the body have three copies of chromosome 13 instead of two. The co...

Read more

The human brain develops through a complex series of events, with genes carefully regulating the formation of neurons and glial cells. A recent study...

Read more

Rare diseases affect between 300 and 400 million people worldwide – more than cancer and AIDS combined [1, 2], but despite this, many people face a...

Read more

Rosalind Elsie Franklin was a brilliant and meticulous research scientist whose interdisciplinary work made fundamental contributions to various area...

Read more

February, designated as Cancer Awareness Month, marks a time to reflect on the remarkable progress made in cancer research and to inspire hope for th...

Read more

Introduction Cardiovascular disease (CVD) is a major health issue as it remains a leading cause of death worldwide [1]. CVD is responsible for mor...

Read more

Antimicrobial resistance (AMR) is one of the most pressing global health threats, and accurate identification and surveillance of multidrug-resistant...

Read more

Colorectal cancer remains a significant health concern globally. While genetic factors play a crucial role in its development, identifying the exact ...

Read more

A new meta-analysis links trans-kingdom gut microbiota (bacteria, eukaryotes, viruses, archaea) to immune checkpoint inhibitor (ICI) response in canc...

Read more